APA (7th ed.) Citation

RJ, S., C, R., HH, J., EY, H., TY, S., EH, R., & SR, B. (2024). Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience. The Laryngoscope, 134(7), 3253. https://doi.org/10.1002/lary.31387

Chicago Style (17th ed.) Citation

RJ, So, Rayle C, Joo HH, Huang EY, Seiwert TY, Raabe EH, and Best SR. "Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience." The Laryngoscope 134, no. 7 (2024): 3253. https://doi.org/10.1002/lary.31387.

MLA (9th ed.) Citation

RJ, So, et al. "Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience." The Laryngoscope, vol. 134, no. 7, 2024, p. 3253, https://doi.org/10.1002/lary.31387.